Nexstim Oy, a medical device company commercializing non-invasive brain diagnostic and therapy technologies, announced in early May that it has obtained an additional equity financing of EUR 2 million, bringing the latest round to EUR 13.4 million. Nexstim is a successful Helsinki-based Neurotech company, which earlier this year received 11.4M€ of financing from the venture arm of the Danish pharma company Lundbeck.
» Read more: www.nextim.com
